Blue Bird (BLBD) ended the recent trading session at $54.48, demonstrating a +1.17% change from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.25% for ...

SOMERVILLE, Mass.--(BUSINESS WIRE)-- bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today announced that it will proceed with a 1-for-20 reverse stock split (“Reverse Stock Split” ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With ...

Blue Bird is likely to remain volatile in the near term, despite the double beat FQ1'25 earnings call and the management's reiterated FY2025 guidance. This is attributed to the lack of clarity ...

That three-month period saw Blue Bird, a longtime manufacturer of school buses, hit new highs for both quarterly revenue and profitability. The former line item zoomed 19% higher to $398 million, ...

Blue Bird Corporation (BLBD) investors likely suffered a shock this week, as the stock gapped down on Monday and was hammered before its earnings release on Wednesday (August 7). Accordingly, the ...

Bluebird Bio (BLUE) came out with a quarterly loss of $2.66 per share versus the Zacks Consensus Estimate of a loss of $3.60. This compares to loss of $7.20 per share a year ago. These figures are ...

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article, we are going to take a look at where bluebird bio, Inc. (NASDAQ:BLUE) stands against the other gene ...

The veteran bus maker delivered a quarter for the ages. It notched new all-time highs in key fundamentals. That three-month period saw Blue Bird, a longtime manufacturer of school buses, hit new highs ...